Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
What does a Democratic blue wave mean for healthcare policy?
Centers for Medicare & Medicaid Services (CMS)
Fierce Pharma
CMS locks in Medicare drug price negotiations for the long haul
CMS is locking in the Medicare drug price negotiation framework established under the Biden-era Inflation Reduction Act.
Fraiser Kansteiner
Nov 6, 2026 4:24pm
Industry Voices—Where healthcare fraud enforcement goes next
Nov 6, 2026 12:59pm
CMS proposes Conditions of Participation rollbacks
Nov 6, 2026 12:00pm
Court blocks CMS' moratorium on new ACA broker registrations
Nov 5, 2026 4:30pm
Final 2027 OPPS has little relief on 340B, site-neutral changes
Nov 5, 2026 10:45am
CMS cuts physician pay, boosts value-based care in 2027 PFS rule
Nov 4, 2026 7:00pm